Meeting Report
What Does Dobbs v. Jackson Mean for Oncology Patients and Providers? Current Considerations for Pregnancy and Fertility in the Oncology Setting
Presented by Brianna Hoffner,(1) MSN, ANP-BC, AOCNP®, FAPO, Leslie C. Appiah,(2) MD, Alexis C. Geppner,(3) MLS, CTTS, MPAS, PA-C, Laxmi A. Kondapalli,(4) MD, MSCE, and Govind Persad,(5) JD, PhD
From (1)BroadcastMed, Farmington, Connecticut; (2)University of Colorado Anschutz Medical Campus, Aurora, Colorado; (3)The University of Texas MD Anderson Cancer Center, Houston, Texas; (4)Colorado Center for Reproductive Medicine, Lone Tree, Colorado; (5)Sturm College of Law, University of Denver, Denver, Colorado
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2023;14(3):191–194 |
https://doi.org/10.6004/jadpro.2023.14.3.2 |
© 2023 Harborside™
ABSTRACT
The incidence of cancers such as colorectal cancer, head and neck cancer, and melanoma has increased in younger patients. The number of cancer survivors is also increasing in the US. Pairing these facts together, there are many people with cancer for whom pregnancy and fertility concerns are crucial aspects of their oncologic and survivorship care. For these patients, understanding and having access to fertility preservation options is an essential part of their care. At JADPRO Live 2022, a panel of experts from diverse professions provided perspectives on the consequences for the treatment landscape after the Dobbs v. Jackson decision.
For access to the full length article, please
sign in.
